Rosenblum Silverman Sutton S F Inc. CA Boosts Stake in Thermo Fisher Scientific Inc (TMO)

Rosenblum Silverman Sutton S F Inc. CA grew its holdings in shares of Thermo Fisher Scientific Inc (NYSE:TMO) by 1.2% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 44,471 shares of the medical research company’s stock after purchasing an additional 513 shares during the period. Thermo Fisher Scientific makes up 3.2% of Rosenblum Silverman Sutton S F Inc. CA’s portfolio, making the stock its 9th biggest holding. Rosenblum Silverman Sutton S F Inc. CA’s holdings in Thermo Fisher Scientific were worth $8,414,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of TMO. Covington Investment Advisors Inc. lifted its stake in Thermo Fisher Scientific by 3.4% during the first quarter. Covington Investment Advisors Inc. now owns 14,158 shares of the medical research company’s stock valued at $2,175,000 after buying an additional 460 shares in the last quarter. BB&T Securities LLC lifted its stake in Thermo Fisher Scientific by 4.4% during the first quarter. BB&T Securities LLC now owns 89,837 shares of the medical research company’s stock valued at $13,798,000 after buying an additional 3,819 shares in the last quarter. Municipal Employees Retirement System of Michigan lifted its stake in Thermo Fisher Scientific by 1.0% during the first quarter. Municipal Employees Retirement System of Michigan now owns 12,750 shares of the medical research company’s stock valued at $1,958,000 after buying an additional 130 shares in the last quarter. ZWJ Investment Counsel Inc. purchased a new stake in Thermo Fisher Scientific during the first quarter valued at about $7,231,000. Finally, Jones Financial Companies Lllp lifted its stake in Thermo Fisher Scientific by 0.3% during the first quarter. Jones Financial Companies Lllp now owns 55,342 shares of the medical research company’s stock valued at $8,501,000 after buying an additional 149 shares in the last quarter. Institutional investors own 85.32% of the company’s stock.

A number of analysts have commented on TMO shares. Cowen and Company reaffirmed an “outperform” rating and set a $220.00 price objective (up from $200.00) on shares of Thermo Fisher Scientific in a research note on Sunday, September 10th. Leerink Swann upped their price objective on shares of Thermo Fisher Scientific from $190.00 to $207.00 and gave the company an “outperform” rating in a research note on Monday, October 9th. Zacks Investment Research lowered shares of Thermo Fisher Scientific from a “buy” rating to a “hold” rating in a research note on Monday, October 30th. Goldman Sachs Group, Inc. (The) initiated coverage on shares of Thermo Fisher Scientific in a research report on Tuesday, September 26th. They issued a “buy” rating and a $225.00 price target for the company. Finally, Deutsche Bank AG set a $226.00 price target on shares of Thermo Fisher Scientific and gave the stock a “buy” rating in a research report on Thursday, October 26th. One equities research analyst has rated the stock with a hold rating and sixteen have assigned a buy rating to the stock. The company presently has an average rating of “Buy” and an average price target of $205.71.

In other Thermo Fisher Scientific news, CEO Marc N. Casper sold 50,000 shares of the stock in a transaction that occurred on Wednesday, November 15th. The stock was sold at an average price of $188.39, for a total transaction of $9,419,500.00. Following the transaction, the chief executive officer now owns 252,577 shares in the company, valued at $47,582,981.03. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director C Martin Harris sold 360 shares of the stock in a transaction that occurred on Wednesday, August 30th. The shares were sold at an average price of $180.97, for a total value of $65,149.20. Following the transaction, the director now owns 5,312 shares in the company, valued at approximately $961,312.64. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 60,420 shares of company stock worth $11,308,477. Insiders own 0.49% of the company’s stock.

Thermo Fisher Scientific Inc (TMO) opened at $191.00 on Tuesday. The firm has a market cap of $76,180.00, a P/E ratio of 20.90, a P/E/G ratio of 1.74 and a beta of 1.08. The company has a current ratio of 1.26, a quick ratio of 0.81 and a debt-to-equity ratio of 0.85. Thermo Fisher Scientific Inc has a 52-week low of $139.07 and a 52-week high of $201.20.

Thermo Fisher Scientific (NYSE:TMO) last issued its quarterly earnings data on Wednesday, October 25th. The medical research company reported $2.31 earnings per share for the quarter, beating the consensus estimate of $2.24 by $0.07. The firm had revenue of $5.12 billion for the quarter, compared to analyst estimates of $5.03 billion. Thermo Fisher Scientific had a net margin of 11.73% and a return on equity of 15.94%. The company’s revenue for the quarter was up 13.9% on a year-over-year basis. During the same quarter last year, the firm earned $2.03 earnings per share. equities analysts expect that Thermo Fisher Scientific Inc will post 9.36 EPS for the current year.

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, January 15th. Investors of record on Friday, December 15th will be given a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a yield of 0.31%. The ex-dividend date is Thursday, December 14th. Thermo Fisher Scientific’s payout ratio is presently 10.19%.

TRADEMARK VIOLATION WARNING: “Rosenblum Silverman Sutton S F Inc. CA Boosts Stake in Thermo Fisher Scientific Inc (TMO)” was published by Sports Perspectives and is the sole property of of Sports Perspectives. If you are accessing this article on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The correct version of this article can be read at https://sportsperspectives.com/2017/11/21/rosenblum-silverman-sutton-s-f-inc-ca-boosts-stake-in-thermo-fisher-scientific-inc-tmo.html.

About Thermo Fisher Scientific

Thermo Fisher Scientific Inc develops, manufactures and sells a range of products. The Company provides analytical instruments, equipment, reagents and consumables, software and services for research, manufacturing, analysis, discovery and diagnostics. It operates through four segments: Life Sciences Solutions, Analytical Instruments, Specialty Diagnostics, and Laboratory Products and Services.

Institutional Ownership by Quarter for Thermo Fisher Scientific (NYSE:TMO)

Receive News & Ratings for Thermo Fisher Scientific Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Thermo Fisher Scientific Inc and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply